• Rania A Najdi, Magda M Hagras, Fatemah O Kamel, and Rania M Magadmi.
• Pharmacology Department, Faculty of Medicine, KAU, Jeddah, Saudi Arabia.
• Afr Health Sci. 2019 Mar 1; 19 (1): 159416011594-1601.

BackgroundHerbal medicines long have been used in the management of diabetes mellitus (DM).ObjectiveThis study was conducted to ascertain if fenugreek compared with glibenclamide had any impacts on controlling blood glucose in patients with uncontrolled type II DM on conventional therapy.MethodsA total of 12 patients with uncontrolled DM and on metformin were recruited and divided into two groups. Patients in group 1 received 2 g fenugreek per day, whereas those in group 2 received glibenclamide 5 mg once daily. The impacts of fenugreek on the glycemic control and lipid profile were measured before initiation of the regimen and then after 12 weeks.ResultsOnly 9 of the 12 study participants completed the study. Fenugreek at 2 g/day caused an insignificant drop in fasting blood glucose (P = 0.63), but the fasting insulin level increased significantly (P = 0.04). The ratio of high- to low-density lipoprotein was significantly decreased from before to after treatment (P = 0.006). Fenugreek did not cause any notable adverse impacts on hepatic and renal functions throughout the study.ConclusionFenugreek could be used as adjuvant therapy to anti-diabetic drugs to control blood glucose, and further studies are needed.

38 keywords...

hide…